CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Heart failure with preserved ejection fraction: from mechanisms to therapies Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Original Research2018 May 15;137(20):2101-2103.

JOURNAL:Circulation. Article Link

Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study

Januzzi JL Jr, Richards AM. Keywords: biomarkers; evidence-based medicine; guideline adherence; heart failure; natriuretic peptides

LINK


Please click on the "Article Link" to access the article.